Target Price Playground
NMAD
$2.35
Forward Projection
If price hits $2 by Jan 15
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Buy a longer-dated put, sell a shorter-dated OTM put. Profits from time decay + a moderate drop.
๐ฏ Target
1-Click Institutional Target Anchors:
60d from today
โ๏ธ Legs
LONG PUT ยท $3 ยท Feb '27
Qty 1 ยท Premium $0.22 ยท ฮ -0.6
SHORT PUT ยท $2 ยท Jan '27
Qty 1 ยท Premium $0.01 ยท ฮ -0.07
P&L at Expiry
Stock (100 sh)
Diagonal Put Spread
Now
Target
๐ก Stock vs Options at Target
If NMAD hits $2 by Jan 15: the diagonal put spread returns +$7 (32.4%) on $21 risked, vs $-12 (-5.1%) for 100 shares on $235. Options give 6.4ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (60 days out). P&L shown is the value at expiry if NMAD is at $2.
๐ Projected Return
P&L if NMAD hits $2 by Jan 15
+$7
+32.4% on $21 risked
Max Profit
+$28
Peak at short put strike ($2) at front-month expiry
Max Loss
โ$21
Net debit paid if stock rallies sharply
Break-even
$2.31
-1.68% from spot
Prob. of Profit at Expiry (PoP)
44.5%
Below breakeven ($2.31)
ยท Touch Target: 67%
30-Day Theta Burn (If Flat)
โ$1
4.9% of entry cost ยท Daily ฮ: $-0.02/day
Net ฮ / ฮ / V
-52.53 / -0.02 / 0.33
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| NMAD Price | Today | Dec 6 | Dec 26 | Jan 15 (exp) |
|---|---|---|---|---|
| $2 (-20%) | +$23 | +$25 | +$27 | +$28 |
| $2 (-15%) | +$19 | +$20 | +$23 | +$28 |
| $2 (-10%) | +$13 | +$14 | +$15 | +$16 |
| $2 (-5%) โ target | +$7 | +$7 | +$7 | +$6 |
| $2 (-2%) | +$3 | +$2 | +$2 | +$1 |
| $2 (0%) โ spot | +$0 | -$1 | -$2 | -$3 |
| $2 (+2%) | -$3 | -$3 | -$5 | -$7 |
| $2 (+5%) | -$6 | -$7 | -$9 | -$11 |
| $3 (+10%) | -$10 | -$12 | -$14 | -$16 |
| $3 (+15%) | -$14 | -$15 | -$17 | -$18 |
| $3 (+20%) | -$16 | -$17 | -$19 | -$20 |
Uses NMAD's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.